Is Cerus Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Cerus Corp (CERS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Cerus Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cerus Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Cerus Corp?

Muslim investors may consider investing in Cerus Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cerus Corp classified as HALAL?

Musaffa determines the Shariah status of Cerus Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cerus Corp updated?

The Shariah compliance status of Cerus Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cerus Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cerus Corp?

You can check the latest Shariah compliance status of Cerus Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CERS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 04, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Cerus Corp (CERS)

Based on 11 analysts giving stock ratings to Cerus Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Cerus Corp. Stock Analysis CERS

United States Health Care Small Cap Report: 2025 Annual

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The company is headquartered in Concord, California and currently employs 281 full-time employees. The firm is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Key Statistics of Cerus Corp (CERS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.55$2.75

Today's Open

$2.75

Volume

2.61M

P/E Ratio (TTM)

52 Week Range

$1.15$3.15

Market Cap

447.56M

Avg. Volume

2.40M

Dividend Yield

Financial Metrics & Statements of Cerus Corp (CERS)

FAQ's for Cerus Corp (CERS)

According to Musaffa’s Shariah screening methodology, Cerus Corp (CERS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.